CALCIFICATION OF SUBCUTANEOUSLY IMPLANTED COLLAGENS IN RELATION TO CYTOTOXICITY, CELLULAR INTERACTIONS AND CROSS-LINKING

被引:39
作者
VANLUYN, MJA [1 ]
VANWACHEM, PB [1 ]
DIJKSTRA, PJ [1 ]
DAMINK, LHHO [1 ]
FEIJEN, J [1 ]
机构
[1] UNIV TWENTE, DEPT CHEM TECHNOL, 7500 AE ENSCHEDE, NETHERLANDS
关键词
D O I
10.1007/BF00120273
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
In general, calcification of biomaterials occurs through an interaction of host and implanted material factors, but up to now the real origin of pathologic calcification is unknown. In this study we aimed to investigate incidence of calcification of (crosslinked) dermal sheep collagens (DSCs) with respect to their specific properties, during subcutaneous implantation in rats. Three types of DSCs were commercially obtained: non-crosslinked DSC (NDSC), and DSC crosslinked with glutaraldehyde (GDSC) and hexamethylenediisocyanate (HDSC). NDSC, HDSC and GDSC were (enzymatically) tissue culture pretreated to eliminate their cytotoxic products. Beside this, crosslinking methods were modified to optimize mechanical properties and to decrease cytotoxicity, which resulted in HDSC* and GDSC*. Furthermore, DSC was crosslinked by activation of the carboxylic groups, i.e. by means of acyl azide and carbodiimide, resulting in AaDSC and CDSC, respectively. After implantation of HDSCs and GDSCs a relation between cytotoxicity and calcification of crosslinked DSC could be made. No relation was found between cellular infiltration of DSCs and calcification. However, from the use of different types and modification of crosslinking methods it might be concluded that calcification is mainly related to stable crosslinks, i.e. to the chemical properties of the obtained material.
引用
收藏
页码:288 / 296
页数:9
相关论文
共 40 条
[1]  
BERNACCA GM, 1992, BIOMATERIALS, V13, P345
[2]   IMPROVED EPON EMBEDDING FOR BIOMATERIALS [J].
BLAAUW, EH ;
OOSTERBAAN, JA ;
SCHAKENRAAD, JM .
BIOMATERIALS, 1989, 10 (05) :356-358
[3]   CHANGES IN THE MECHANICAL-PROPERTIES OF DERMAL SHEEP COLLAGEN DURING IN-VITRO DEGRADATION [J].
DAMINK, LHHO ;
DIJKSTRA, PJ ;
VANLUYN, MJA ;
VANWACHEM, PB ;
NIEUWENHUIS, P ;
FEIJEN, J .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1995, 29 (02) :139-147
[4]  
Ferrans V. J., 1988, COLLAGEN, V3, P145
[5]   PHASE TRANSITIONS IN COLLAGEN AND GELATIN SYSTEMS [J].
FLORY, PJ ;
GARRETT, RR .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1958, 80 (18) :4836-4845
[6]   PREVENTION OF BIOPROSTHETIC HEART-VALVE TISSUE CALCIFICATION BY CHARGE MODIFICATION - EFFECTS OF PROTAMINE BINDING BY FORMALDEHYDE [J].
GOLOMB, G ;
EZRA, V .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1991, 25 (01) :85-98
[7]  
GOLOMB G, 1987, AM J PATHOL, V127, P122
[8]   MECHANICAL-PROPERTIES AND HISTOLOGY OF CHARGE MODIFIED BIOPROSTHETIC TISSUE RESISTANT TO CALCIFICATION [J].
GOLOMB, G ;
LEWINSTEIN, I ;
EZRA, V ;
SCHOEN, FJ .
BIOMATERIALS, 1992, 13 (06) :353-356
[9]   BISACYLPHOSPHONATES INHIBIT HYDROXYAPATITE FORMATION AND DISSOLUTION INVITRO AND DYSTROPHIC CALCIFICATION INVIVO [J].
GOLOMB, G ;
SCHLOSSMAN, A ;
SAADEH, H ;
LEVI, M ;
VANGELDER, JM ;
BREUER, E .
PHARMACEUTICAL RESEARCH, 1992, 9 (01) :143-148
[10]   CONTROLLED-RELEASE DRUG DELIVERY OF DIPHOSPHONATES TO INHIBIT BIOPROSTHETIC HEART-VALVE CALCIFICATION - RELEASE RATE MODULATION WITH SILICONE MATRICES VIA DRUG SOLUBILITY AND MEMBRANE COATING [J].
GOLOMB, G ;
DIXON, M ;
SMITH, MS ;
SCHOEN, FJ ;
LEVY, RJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (04) :271-276